Corvus Pharmaceuticals (CRVS) Insider Trading & Ownership → Warren Buffett's 'mystery stock' (From Stansberry Research) (Ad) Free CRVS Stock Alerts $2.29 0.00 (0.00%) (As of 01:56 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Corvus Pharmaceuticals (NASDAQ:CRVS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage31.30%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$1.03 MNumber OfInsiders Selling(Last 12 Months)0 Get CRVS Insider Trade Alerts Want to know when executives and insiders are buying or selling Corvus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CRVS Insider Buying and Selling by Quarter Ad InvestorPlaceBoost your retirement with these AI payoutsBREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. Corvus Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/6/2024Richard A Md MillerCEOBuy577,634$1.73$999,306.82 5/6/2024William Benton JonesInsiderBuy20,000$1.73$34,600.00 (Data available from 1/1/2013 forward) CRVS Insider Trading Activity - Frequently Asked Questions Who is on Corvus Pharmaceuticals's Insider Roster? The list of insiders at Corvus Pharmaceuticals includes Ecor1 Capital, Llc, Leiv Lea, Linda Grais, Orbimed Advisors Llc, Richard A Md Miller, and William Benton Jones. Learn more on insiders at CRVS. What percentage of Corvus Pharmaceuticals stock is owned by insiders? 31.30% of Corvus Pharmaceuticals stock is owned by insiders. Learn more on CRVS's insider holdings. Which Corvus Pharmaceuticals insiders have been buying company stock? The following insiders have purchased CRVS shares in the last 24 months: Leiv Lea ($22,200.00), Linda Grais ($24,500.00), Richard A Md Miller ($1,087,455.72), and William Benton Jones ($50,400.00). How much insider buying is happening at Corvus Pharmaceuticals? Insiders have purchased a total of 768,524 CRVS shares in the last 24 months for a total of $1,184,555.72 bought. More Insider Trading Tools from MarketBeat Related Companies: JAGX Insider Transactions HOOK Insider Transactions LFVN Insider Transactions TPST Insider Transactions MRNS Insider Transactions RVPH Insider Transactions ANEB Insider Transactions BTAI Insider Transactions VACC Insider Transactions QTTB Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock Lately This page (NASDAQ:CRVS) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock Digest Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corvus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.